The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, including some employees reviewing Elon Musk's brain implant company, Neuralink,

The FDA is trying to rehire 300 recently fired scientists, including some who reviewed Elon Musk's Neuralink. The move follows mass layoffs under the Trump administration, sparking concerns over job security and federal workforce strategy.

U.S. Food and Drug Administration employees reviewing Elon Musk’s brain implant company Neuralink were fired over the weekend as part of a broader purge of the federal workforce, according to two sources with knowledge of the matter.

Reportedly among the recent job cuts at the FDA were workers overseeing the review of Musk’s brain chip-implant company, Neuralink. Since the moment the Department of Government Efficiency (DOGE) was first proposed,

The FDA is considering rehiring recently dismissed scientists who were involved in projects like Elon Musk's Neuralink. About 300 positions are expected to be reinstated after mass firings by the Trump administration.

A wave of federal job cuts initiated by the Department of Government Efficiency (DOGE) is impacting regulatory agencies investigating Elon Musks companies, including the US Food and Drug Administration (FDA).

Americans need “an efficient, effective FDA review process that helps advance the medical technologies American patients depend on. Bringing these specific experts back would help fulfill that mission," said Scott Whitaker, CEO of the medical device industry group AdvaMed, which had criticized the firings.

The FDA plans to rehire around 300 people in total, according to four sources with secondhand knowledge of the situation, following President Donald Trump’s rush last week to fi